Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, Minnesota


Purpose:

The purpose of the study is to measure tumor response rates for three schedules of Alimta(LY231514) in combination with gemcitabine in patients with locally advanced or metastatic non small cell lung cancer who have received no prior chemotherapy regimen.


Criteria:

Inclusion Criteria: - Diagnosis of non-small lung cancer - No prior chemotherapy - Able to care for self Exclusion Criteria: - An ongoing infection - Pregnancy or breast feeding - Other serious medical condition - Cancer that has spread to the brain - Inability to take folic acid


NCT ID:

NCT00034606


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.